Literature DB >> 19531792

International differences in the treatment of sepsis: are they justified?

John A Kellum, Shigehiko Uchino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19531792     DOI： 10.1001/jama.2009.850

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Blood purification and mortality in sepsis: a meta-analysis of randomized trials.

Authors:  Feihu Zhou; Zhiyong Peng; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

2.  Clinical trial report-polymyxin B hemoperfusion: effective, or not?

Authors:  Jean-Louis Vincent
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

Review 3.  The implications and management of septic acute kidney injury.

Authors:  Zaccaria Ricci; Andrea Polito; Angelo Polito; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

4.  Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?

Authors:  Nitin Seam; Anthony F Suffredini
Journal:  Crit Care       Date:  2014-11-25       Impact factor: 9.097

5.  Sepsis: clearing the blood in sepsis.

Authors:  Jean-Louis Vincent
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

Review 6.  Clinical review: blood purification for sepsis.

Authors:  Thomas Rimmelé; John A Kellum
Journal:  Crit Care       Date:  2011-02-16       Impact factor: 9.097

7.  Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study.

Authors:  Thomas Rimmelé; Ata Murat Kaynar; Joseph N McLaughlin; Jeffery V Bishop; Morgan V Fedorchak; Anan Chuasuwan; Zhiyong Peng; Kai Singbartl; Daniel R Frederick; Lin Zhu; Melinda Carter; William J Federspiel; Adriana Zeevi; John A Kellum
Journal:  Crit Care       Date:  2013-03-26       Impact factor: 9.097

8.  The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.

Authors:  David J Klein; Debra Foster; Christa A Schorr; Kazem Kazempour; Paul M Walker; R Phillip Dellinger
Journal:  Trials       Date:  2014-06-11       Impact factor: 2.279

Review 9.  A systematic review for pursuing the presence of antibiotic associated enterocolitis caused by methicillin resistant Staphylococcus aureus.

Authors:  Kentaro Iwata; Asako Doi; Takahiko Fukuchi; Goh Ohji; Yuko Shirota; Tetsuya Sakai; Hiroki Kagawa
Journal:  BMC Infect Dis       Date:  2014-05-09       Impact factor: 3.090
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.